🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06471309
Enrolling by invitation Not applicable

Effect of Theta Burst Transcranial Magnetic Stimulation on Patients with Dysphagia After Stroke

NCT06471309 · tracked via the Priya Life Science China tracker
Sponsor
Zhang Xiaohui
Phase
Not applicable
Started
2024-08-02
Last updated
2024-09-27

Condition(s) studied

StrokeDysphagiaFunctional Near- Infrared SpectroscopyTranscranial Magnetic Stimulation

Investigational drug(s) / intervention(s)

Theta burst transcranial magnetic stimulation

Theta burst transcranial magnetic stimulation: The stimulation intensity of TBS was 80%RMT, with a total of 600 pulses, five times a week for two weeks. In the bilateral stimulation group, iTBS treatment was given to the representative area of mylohyoid cortex on the affected side and cTBS treatment was given to the representative area of mylohyoid cortex on the healthy side. In the unilateral stimulation group, iTBS treatment was given to the representative area of mylohyoid cortex on the affected side and sham cTBS treatment was given to the representative area of mylohyoid cortex on the healthy side. In the sham stimulation group, sham iTBS treatment was given to the representative area of mylohyoid cortex on the affected side and sham cTBS treatment was given to the representative area of mylohyoid cortex on the healthy side. When giving sham stimulation, put the coil vertically so that the coil is perpendicular to the patient's skull surface , it will not produce real therapeutic effect.

Study summary

The purpose of this study was to observe the effect of Theta burst transcranial magnetic stimulation (TBS) on swallowing function in patients with dysphagia after stroke (PSD). Functional near- infrared spectroscopy (fNIRS) was used to detect the changes in activation and functional connectivity of related brain regions in PSD patients treated with intermittent TBS(iTBS)stimulation on the affected side and consistent TBS(cTBS) stimulation on the healthy side. To investigate the effects of TBS on swallowing related cortical excitability in stroke patients with dysphagia and explore its possible mechanism, and provide theoretical basis for the treatment of PSD patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-80 years old * The first stroke lasted from 2 weeks to 6 months, with stable vital signs and right-handedness * The stroke met the diagnostic criteria of "Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage 2019" or "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018" formulated by the Cerebrovascular Department of the Branch of Neurology of the Chinese Medical Association, and the cerebral CT or MRI examination showed unilateral cerebral infarction or cerebral hemorrhage. * The dysphagia was consistent with the Expert Consensus on the Evaluation and Treatment of dysphagia in China (2017 edition), and the dysphagia was confirmed by videofluoroscopic swallowing study. * MMSE\>24, good cognitive function * The skull is intact without craniotomy or repair * Subject or family members sign informed consent Exclusion Criteria: * Combined with other diseases that may cause swallowing disorders, such as Parkinson's disease, dementia, motor neurone disease and other neurological diseases, or esophageal, neck surgery and other diseases that cause swallowing organ structure abnormalities * A history of mental illness or epilepsy * A metal implant in the head or eye, a pacemaker or a drug pump in the body * Pregnancy, malignant tumor, serious disease history of heart, liver, kidney and other important organs * Ulceration or infection of the skin on the head or where the electrode is applied * Poor compliance and inability to complete basic treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06471309 on ClinicalTrials.gov ↗ ← All trials in China